IPO Watch: Clarity the latest ASX radiopharmaceutical company, Vulcan Energy spin-off ahead
Rene Anthony
As the US IPO pipeline currently builds amid the seasonal lull in new listings, attention will shift to three upcoming floats that are locked in for the ASX this week.
Clarity Pharmaceuticals (ASX: CU6) is the most high-profile listing on the horizon, with the radiopharmaceutical company set to debut Wednesday. Founded in 2010, and with as many as five clinical trials currently underway, the company is hoping to develop a series of next-generation theranostic products using copper radioisotopes for the diagnosis and treatment of a range of conditions, including various forms of cancer. Clarity will come to market with a value of nearly $360 million.The other names on this week watch-list include two junior explorers. Kuniko (ASX: KNI) is a spin-off born out of high-flying Vulcan Energy Resources (ASX: VUL), with the company looking to apply a zero carbon focus to its exploration for copper, nickel and cobalt across projects in Norway. Culpeo Minerals (ASX: CPO) will also have an international focus, with the explorer focused on tenements in the number one copper-producing nation, Chile.
Upcoming IPOs
ASX Market:
Kuniko (KNI)
Focus: Copper, nickel, and cobalt explorer
IPO Size: $7.89 million
Expected Debut: August 24
Culpeo Minerals (CPO)
Focus: Copper explorer
IPO Size: $6 million
Expected Debut: August 24
Clarity Pharmaceuticals (CU6)
Focus: Radiopharmaceutical theranostic developer
IPO Size: $92 million
Expected Debut: August 25
*All dates are subject to change and should be treated as an indicative guide only
Future Listings
Several other junior explorers are making efforts to list on the ASX in the coming weeks, including copper explorer Recharge Metals, which is raising $5 million at $0.20 per share, as well as Resilience Mining and Alvo Minerals.
Recharge Metals holds tenements in the Hyden and Mueller Ranges, as well as at Brandy Hill, which is south of the gold-copper mine operated by Silver Lake Resources (ASX: SLR). Meanwhile, Alvo Minerals is a junior explorer in the copper and zinc space, eyeing up to $10 million for its projects across Brazil, and Resilience Mining is targeting $6 million in fresh capital to explore land in Mongolia that it believes is prospective for copper and gold.
Elsewhere, telecoms software provider ActivePort is currently in the middle of its IPO raise, having blitzed through the minimum $10 million subscription and now targeting $15 million. The company software is used for centralised management of data networks, with funds from the IPO set to be used to expand overseas.While no new IPOs are scheduled in the US over the coming days, a host of new filings were submitted last week for upcoming listings. Leading the way is tech consultancy business Thoughtworks (TWKS), which plans to raise up to US$500 million. A number of businesses are raising in the vicinity of US$100 million, including Swiss sports data and betting company Sportradar Group (SRAD), surgical robotics developer PROCEPT BioRobotics (PRCT), human resource platform iCIMS Holding (TLNT), oncology biotech Tyra Biosciences (TYRA), coffee chain Dutch Bros (BROS), and health care intelligence platform Definitive Healthcare (DH). One Australian firm is also looking to get in on the action, with drug developer Incannex Healthcare (IXHL) unveiling plans to raise US$27 million.
Be sure to keep an eye out for our end-of-week bulletin covering all the major results among new ASX and US IPOs.
Important disclaimer: SelfWealth Ltd ABN 52 154 324 428 (“Selfwealth”) (AFSL 421789). The information contained on this website is general in nature and does not take into account your personal situation. You should consider whether the information is appropriate to your needs, and where appropriate, seek professional advice from a financial adviser and/or accountant. Taxation, legal and other matters referred to on this website are of a general nature only and should not be relied upon in place of appropriate professional advice. You should obtain the relevant Product Disclosure Statement for any product mentioned and consider its contents before making any decision.